Vipin K. Garg

2021

In 2021, Vipin K. Garg earned a total compensation of $2.6M as Chief Executive Officer at PharmAthene, a 83% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$289,988
Option Awards$1,326,049
Salary$565,673
Stock Awards$436,133
Other$13,796
Total$2,631,639

Garg received $1.3M in option awards, accounting for 50% of the total pay in 2021.

Garg also received $290K in non-equity incentive plan, $565.7K in salary, $436.1K in stock awards and $13.8K in other compensation.

Rankings

In 2021, Vipin K. Garg's compensation ranked 4,952nd out of 12,415 executives tracked by ExecPay. In other words, Garg earned more than 60.1% of executives.

ClassificationRankingPercentile
All
4,952
out of 12,415
60th
Division
Manufacturing
2,078
out of 5,505
62nd
Major group
Chemicals And Allied Products
886
out of 2,375
63rd
Industry group
Drugs
793
out of 2,096
62nd
Industry
Pharmaceutical Preparations
565
out of 1,546
64th
Source: SEC filing on August 16, 2022.

Garg's colleagues

We found four more compensation records of executives who worked with Vipin K. Garg at PharmAthene in 2021.

2021

M Harris

PharmAthene

Chief Medical Officer

2021

M Roberts

PharmAthene

Chief Scientific Officer

2021

William Brown

PharmAthene

Chief Financial Officer

2021

Richard Eisenstadt

PharmAthene

Chief Financial Officer

News

In-depth

You may also like